abstract |
The present invention relates to novel 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives of formula I, processes for their preparation, pharmaceutical compositions containing them and their use as N-formyl peptide-like receptors. Use of a medicament that is a modulator of the body-1 (FPRL-1) receptor. |